Amiodarone Hcl 100 Mg Tablet Suppliers & Bulk Manufacturers
Available Forms: Tablets
Available Strengths: 100 mg, 200 mg, 400 mg
Reference Brands: Pacerone(US), Cordarone
Category:
Critical Care
Amiodarone is a key antiarrhythmic drug available in 100–400 mg tablets and 50 mg/mL IV vials. Used for serious ventricular arrhythmias, brands include Cordarone and Amiodarone Hameln. Commonly supplied to hospitals and ICUs, it is a staple in pharma B2B cardiac care procurement and institutional sourcing platforms.
Amiodarone Hcl 100 mg Tablet is available in Tablets
and strengths such as 100 mg, 200 mg, 400 mg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Amiodarone Hcl 100 mg Tablet is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Amiodarone Hcl 100 mg Tablet can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Amiodarone is a widely prescribed anti-arrhythmic medication primarily approved by the U.S. Food and Drug Administration (FDA) for the treatment of life-threatening ventricular arrhythmias. It helps restore normal heart rhythm by prolonging the cardiac action potential and refractory period, stabilizing electrical activity within the heart. Beyond its approved use, amiodarone is frequently employed off-label to manage supraventricular tachyarrhythmias, including atrial fibrillation, and to prevent recurrent ventricular tachyarrhythmias in high-risk patients.
Amiodarone’s unique pharmacological profile allows it to act on multiple cardiac ion channels, providing both rate control and rhythm stabilization. The drug is administered orally or intravenously, depending on the clinical setting and urgency of therapy. While highly effective, amiodarone use requires careful monitoring due to potential adverse effects, including thyroid dysfunction, pulmonary toxicity, hepatic impairment, and ocular complications. Awareness of contraindications, drug interactions, and patient-specific factors is essential for safe therapy.
Healthcare professionals benefit from a comprehensive understanding of amiodarone’s indications, mechanisms, and safety profile to optimize treatment outcomes. Close interprofessional collaboration ensures effective arrhythmia management while minimizing risks, making amiodarone a cornerstone in the care of patients with complex cardiac rhythm disorders.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing